A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2006
10/12/2006	WO2006107334A1 Dissolvable tooth whitening strip
10/12/2006	WO2006107330A1 Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
10/12/2006	WO2006107097A1 Nasal vaccine
10/12/2006	WO2006107009A1 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device
10/12/2006	WO2006106926A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
10/12/2006	WO2006106923A1 Disintegrating tablet in oral cavity and process for producing the same
10/12/2006	WO2006106889A1 Methods of producing sodium alginate-containing tablet and tablets obtained by the production methods
10/12/2006	WO2006106887A1 Edible composition containing component extracted from salix sp. extract
10/12/2006	WO2006106815A1 Tablet
10/12/2006	WO2006106805A1 Method of improving the storage stability of substance
10/12/2006	WO2006106799A1 Microcapsule using polyvinyl alcohol copolymer
10/12/2006	WO2006106521A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
10/12/2006	WO2006106520A2 Solvent-free process for preparation of hydrophilic dispersions of nanoparticles of inclusion complexes
10/12/2006	WO2006106519A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
10/12/2006	WO2006106514A2 Electrospun dosage form and method of producing the same
10/12/2006	WO2006106400A2 Capsules containing seminal material for artificial insemination
10/12/2006	WO2006106398A1 Method for improving sensory characteristics of semisolid predominantly anhydrous lipids
10/12/2006	WO2006106350A1 Anti-inflammatory formulation
10/12/2006	WO2006106344A2 Abuse resistant capsules
10/12/2006	WO2006105798A2 Benzimidazole formulation
10/12/2006	WO2006105666A1 Administration of macrophage targeted formulations of compounds which modulate cholesterol-metabolizing enzymes for treatment of atherosclerosis
10/12/2006	WO2006105665A1 Hydrogel composition for modulation of topical inflammatory response
10/12/2006	WO2006105659A1 Hydrophilic core polymeric micelles for the delivery of water-soluble compounds
10/12/2006	WO2006105643A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor
10/12/2006	WO2006105630A1 A cosmetic composition, a pharmaceutical composition and a process for preparing said compositions
10/12/2006	WO2006105615A1 Buccal delivery system
10/12/2006	WO2006081088A8 Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an nsaid
10/12/2006	WO2006066868A3 Sustained release formulation comprising bisphosphonate
10/12/2006	WO2006065420A3 Th2-inducing adjuvant treatment for osteolysis
10/12/2006	WO2006060681A3 Pharmaceutical composition containing an anti-nucleating agent
10/12/2006	WO2006052968A3 Stabilized ramipril compositions and methods of making
10/12/2006	WO2006050926A3 Extended surface aggregates in the treatment of skin conditions
10/12/2006	WO2006038916A3 Scored pharmaceutical tablets comprising a plurality of segments
10/12/2006	WO2006023814A3 Effervescent composition including a grape-derived component
10/12/2006	WO2006021709A3 Anhydrous solid particle containing a lipid composition and pharmaceutical composition containing said particles
10/12/2006	WO2006007136A3 Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
10/12/2006	WO2006000583A3 Oral sustained release formulation of tedisamil with gastric retention properties
10/12/2006	WO2005115380B1 Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins
10/12/2006	WO2005092297A3 A stable pharmaceutical composition comprising an acid labile drug
10/12/2006	WO2005089729A3 Galenic formulations of organic compounds
10/12/2006	WO2005030132A3 Therapeutic regimens for administering drug combinations
10/12/2006	WO2002098389A8 Method of forming an aerosol for inhalation delivery
10/12/2006	US20060229706 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
10/12/2006	US20060229588 Irrigation solution and method for inhibition of pain and inflammation
10/12/2006	US20060229383 Novel coating composition
10/12/2006	US20060229359 Tocopherol-modified therapeutic drug compounds
10/12/2006	US20060229340 Composition for improving cognition and memory
10/12/2006	US20060229331 Ketoprofen compositions and methods of making them
10/12/2006	US20060229246 Peptide-enhanced transfections
10/12/2006	US20060229245 Lyophilized HGF preparations
10/12/2006	US20060229238 Sustained release of microcrystalline peptide suspensions
10/12/2006	US20060228570 Reactor coated with a polymer
10/12/2006	US20060228427 Solid mucoadhesive composition
10/12/2006	US20060228422 Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration
10/12/2006	US20060228421 Device for moving magnetic nanoparticles through tissue
10/12/2006	US20060228420 Pharmaceutical compositions comprising microparticles for delivery into neurons
10/12/2006	US20060228419 Solvent-free process for preparation of hydrophilic dispersions of nanoparticles of inclusion complexes
10/12/2006	US20060228418 Topical ointment and method for making and using same
10/12/2006	US20060228417 Mucoadhesive composition comprising polyacrylate and chemoattractant
10/12/2006	US20060228416 Methods for modulating topical inflammatory response
10/12/2006	US20060228415 Comprising core of bupropion hydrochloride, binder, lubricant, control releasing coat, moisture barrier surrounding coat; advantage of tablets of invention not afforded by prior art commercially available tablets is that they allow for a once daily administration and do not exhibit food effect
10/12/2006	US20060228414 Method for the preparation of controlled release formulations
10/12/2006	US20060228413 Controlled release venlafaxine formulations
10/12/2006	US20060228412 (-)-Hydroxycitric acid for delaying gastric emptying
10/12/2006	US20060228411 Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
10/12/2006	US20060228410 Flavored taste-masked pharmaceutical formulation made using a one-step coating process
10/12/2006	US20060228409 Scored tablet
10/12/2006	US20060228408 Drug delivery system
10/12/2006	US20060228407 Enhanced delivery via serpin enzyme complex receptor
10/12/2006	US20060228406 Transfection reagent for non-adherent suspension cells
10/12/2006	US20060228405 ansamycins such as 17-allylaminogeldanamycin (17-AAG) and the overall formulation is free of medium and long chain triglycerides; can be freeze dried, sterilized; provide for higher concentrations of lipophilic compound per aqueous physiological unit volume
10/12/2006	US20060228404 Compositions and methods for treatment of hypertrophic tissues
10/12/2006	US20060228403 Nutritional supplements for cardiovascular health
10/12/2006	US20060228402 Techniques for forming a lipid bilayer membrane
10/12/2006	US20060228401 Templating an extracellular biopolymer matrix for use in generating corneal stroma, and other structured connective tissue such as a ligament, a tendon, a fascia and annulus fibrosis; improved process control
10/12/2006	US20060228395 Vitamin E phosphate/phosphatidylcholine liposomes to protect from or ameliorate cell damage
10/12/2006	US20060228394 Ocular solutions
10/12/2006	US20060228393 Ocular solutions
10/12/2006	US20060228385 Sustained release of microcrystalline peptide suspensions
10/12/2006	US20060228383 comprising a fluoroether anesthetic compound selected from sevoflurane, desflurane, isoflurane, enflurane and methoxyflurane, and at least one stabilizer agent selected from propylene glycol, polyethylene glycol, hexylene glycol, 1,3-butylene glycol and a saturated cyclic alcohol preferably menthol
10/12/2006	US20060228376 Virosome-like-particles
10/12/2006	US20060228373 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant
10/12/2006	US20060228347 Antitumor agent and dnase
10/12/2006	US20060228306 Combination antihistamine and steroid medication
10/12/2006	US20060228299 Constructs binding to phosphatidylserine and their use in disease treatment
10/12/2006	US20060226080 Bicarbonate-based peritoneal dialysis solutions
10/12/2006	US20060225610 Edible phosphoprotein film
10/12/2006	DE20321314U1 Retarded release pharmaceutical composition, obtained without use of organic solvents or water by densifying mixture of active agent and retarding polymer in heated rollers
10/12/2006	DE19940944B4 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms
10/12/2006	DE102005016193A1 Preparing polymer molded part with porous structure, useful as e.g. package, comprises adding fluid active substance into polymer; subjecting the obtained dispersion to ultrasonics, and solidifying the dispersion under cooling/hardening
10/12/2006	DE102005014424A1 Neue Tenside und neue Emulgatoren auf der Basis von Disacchariden New surfactants and emulsifiers on the basis of new disaccharides
10/12/2006	DE10064219B4 Neue Fentanyl und/oder dessen Derivate enthaltende enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung New fentanyl and / or derivatives thereof containing containing pharmaceutical composition for nasal administration
10/12/2006	CA2614526A1 Benzimidazole formulation
10/12/2006	CA2605386A1 Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
10/12/2006	CA2605185A1 Matrix-based pulse release pharmaceutical formulation
10/12/2006	CA2604861A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor
10/12/2006	CA2604599A1 Hydrophilic core polymeric micelles for the delivery of water-soluble compounds
10/12/2006	CA2603689A1 Capsules containing seminal material for artificial insemination
10/12/2006	CA2603649A1 Buccal delivery system
10/12/2006	CA2603512A1 Anti-inflammatory formulation

1 ... 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 ... 2991